@Barcode:$Adobe(ADBE)$ $Workday(WDAY)$  $Intuit(INTU)$  📉 Adobe Liquidity Flush, Valuation Reset, Big Money Setup 📊 I’m watching Adobe $ADBE get absolutely smacked today, now -4.5% to $334.29, and it’s dragging the software complex with it as $WDAY and $INTU slide in sympathy. This is not noise. This is volatility asserting control and forcing rotation. On the charts, the message is unmissable. The recent rally was rejected cleanly at the 200DMA resistance. On the 4H and 30m views, price smashed through the mid Keltner, accelerated into the lower volatility bands, and printed a textbook liquidity flush. Wide ranges, heavy red candles, urgency everywher

@Barcode:$Interactive Brokers(IBKR)$ $Goldman Sachs(GS)$  $JPMorgan Chase(JPM)$ 🥊📈 Retail Just Beat Wall Street for a Third Straight Year, and the Data Is Now Undeniable 📊🔥💰 👀📈 I’m looking at this chart attached and it captures something structural, not cyclical. 📌📊 What the data actually says • $IBKR: Retail average return 19.2% vs S&P 500 17.9% • $GS: “Retail favourites” basket +30.5% vs S&P 500 +16.4% • $JPM: AI and metals trades drove 40%+ of retail gains For the third consecutive year, retail capital has outperformed the S&P 500. This is no longer anecdotal and it’s no longer narrow. It’s confirmed across independent datasets from Goldman

@PetS:🥂🍾👏🙌🥳 Huge congrats to @Barcode 👏📈. That $NVIDIA(NVDA)$ breakdown wasn’t flashy, it was precise. Clear downside mapping, volatility awareness and respect 🫡 for macro pressure points. Honestly your $Tesla Motors(TSLA)$ posts carried the same DNA 🚗⚡. This Top 10 spot feels fully earned!

@Barcode:$Tesla Motors(TSLA)$ $Direxion Daily TSLA Bull 2X Shares(TSLL)$  $NIO Inc.(NIO)$  🚨📊 Tesla Just Took Control of Wall Street’s Expectations 📊🚨📰 30 Dec 2025 🇺🇸 | 31 Dec 2025 🇳🇿🥳 I’m flagging this because it’s genuinely rare. 🚨📰 NEWS: Tesla has published street delivery estimates themselves, via a company-compiled sell-side

@Barcode:$Ultragenyx Pharmaceutical(RARE)$ $Spdr S&P Biotech Etf(XBI)$  $iShares Biotechnology ETF(IBB)$  🧬🎯 Brittle Endpoint, Resilient Helix 🎯🧬 When a price cut sharpens the aim, not the thesis 🚨📰 Just in: $RARE proves you can put the target on a diet without starving the thesis. 🏦 Wells Fargo cut its price target on $RARE to $45 from $65 while maintaining Overweight. I read this as probability discipline, not loss of conviction. At roughly $19.72, the revised framework still implies about 128% upside, reframing the move as risk calibration rather than thesis erosion. ✂️ The reset followed Ultragenyx’s setrusumab miss in osteogenesis imperfecta, wh